Screening for ovarian cancer

被引：18

作者：

Anderiesz, C

Quinn, MA

机构：

[1] Natl Canc Control Initiat, Carlton, Vic, Australia

[2] Frances Perry House, Carlton, Vic, Australia

来源：

MEDICAL JOURNAL OF AUSTRALIA | 2003年 / 178卷 / 12期

关键词：

D O I：

10.5694/j.1326-5377.2003.tb05399.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Ovarian cancer is the leading cause of death from gynaecological malignancies. No precancerous lesions have been identified. Bimanual examination has not been proven to be of value as a screening test. Transvaginal ultrasound examination, with or without measurement of CA 125 levels, is currently being evaluated for population screening. Women at high risk of ovarian cancer should be screened annually-with measurement of CA 125 level and transvaginal ultrasound examination.

引用

页码：655 / 656

页数：2

共 9 条

[1]

*AUSTR BUR STAT, 2001, CENS POP HOUS SOC IN, P1

[2]

BROMLEY B, 1994, OBSTET GYNECOL, V83, P434

[3] BRCA1/2 genetic testing in the community setting [J].